Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement-Reference-Cited by-同舟云学术

Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement

Published:2013-06-30 Issue:2 Volume:45 Page:112-117
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Kang Byung Woog,Moon Joon Ho,Chae Yee Soo,Lee Soo Jung,Kim Jong Gwang,Kim Yeo-Kyeoung,Lee Je-Jung,Yang Deok-Hwan,Kim Hyeoung-Joon,Kim Jin Young,Do Young Rok,Park Keon Uk,Song Hong Suk,Kwon Ki Young,Kim Min Kyung,Lee Kyung Hee,Hyun Myung Soo,Ryoo Hun Mo,Bae Sung Hwa,Kim Hwak,Sohn Sang Kyun

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://www.e-crt.org/upload/pdf/crt-45-112.pdf

Reference20 articles.

1. Bone Marrow Involvement by Hodgkin and Non-Hodgkin Lymphomas

2. Bone Marrow Biopsy Involvement by Non-Hodgkin's Lymphoma

3. Diffuse Large B-Cell Lymphoma Initially Manifesting in the Bone Marrow

4. Rituximab in High-Grade Lymphoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A predictive diagnostic model for refractory diffuse large B-cell lymphoma: a single-center retrospective cohort study;2023-12-11

2. Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma;Diagnostics;2021-09-20

3. Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility;PLOS ONE;2018-07-18

4. Non-Hodgkin Lymphomas: Impact of Rituximab on Overall Survival of Patients with Diffuse Large B-Cell and Follicular Lymphoma;Archives of Medical Research;2015-08

5. HIV-infection impact on clinical–biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era;AIDS;2015-04-24